 |
antagonist of the complement 5a receptor |
|---|---|
| Trade Name | |
| Orphan Indication | Atypical hemolytic uremic syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2014-11-17 00:00:00 |
| Sponsor | ChemoCentryx, Inc.;850 Maude Avenue;Mountain View, California, 94043 |
| |
antagonist of the complement 5a receptor |
|---|---|
| Trade Name | |
| Orphan Indication | Atypical hemolytic uremic syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2014-11-17 00:00:00 |
| Sponsor | ChemoCentryx, Inc.;850 Maude Avenue;Mountain View, California, 94043 |